Literature DB >> 10441328

Nuclear localization of the spinocerebellar ataxia type 7 protein, ataxin-7.

M D Kaytor1, L A Duvick, P J Skinner, M D Koob, L P Ranum, H T Orr.   

Abstract

Spinocerebellar ataxia type 7 (SCA7) belongs to a group of neurological disorders caused by a CAG repeat expansion in the coding region of the associated gene. To gain insight into the pathogenesis of SCA7 and possible functions of ataxin-7, we examined the subcellular localization of ataxin-7 in transfected COS-1 cells using SCA7 cDNA clones with different CAG repeat tract lengths. In addition to a diffuse distribution throughout the nucleus, ataxin-7 associated with the nuclear matrix and the nucleolus. The location of the putative SCA7 nuclear localization sequence (NLS) was confirmed by fusing an ataxin-7 fragment with the normally cytoplasmic protein chicken muscle pyruvate kinase. Mutation of this NLS prevented protein from entering the nucleus. Thus, expanded ataxin-7 may carry out its pathogenic effects in the nucleus by altering a matrix-associated nuclear structure and/or by disrupting nucleolar function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10441328     DOI: 10.1093/hmg/8.9.1657

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  18 in total

Review 1.  Multi-tasking on chromatin with the SAGA coactivator complexes.

Authors:  Jeremy A Daniel; Patrick A Grant
Journal:  Mutat Res       Date:  2007-01-21       Impact factor: 2.433

2.  Localization and importance of the adenovirus E4orf4 protein during lytic infection.

Authors:  Marie-Joëlle Miron; Paola Blanchette; Peter Groitl; Frederic Dallaire; Jose G Teodoro; Suiyang Li; Thomas Dobner; Philip E Branton
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

3.  The SAGA histone deubiquitinase module controls yeast replicative lifespan via Sir2 interaction.

Authors:  Mark A McCormick; Amanda G Mason; Stephan J Guyenet; Weiwei Dang; Renee M Garza; Marc K Ting; Rick M Moller; Shelley L Berger; Matt Kaeberlein; Lorraine Pillus; Albert R La Spada; Brian K Kennedy
Journal:  Cell Rep       Date:  2014-07-18       Impact factor: 9.423

4.  Spinocerebellar ataxia Type 7: clinical and genetic study of a new Moroccan family (case report).

Authors:  Fatima Zahra Bouzid; Maria Mansouri; Chaikhy Abdelaziz; Nisrine Louhab; Sablonniere Bernard; Isabelle Strubi-Vuillaume; Kenza Dafir; Nisrine Aboussair
Journal:  Pan Afr Med J       Date:  2021-02-12

5.  Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains.

Authors:  B O Evert; I R Vogt; C Kindermann; L Ozimek; R A de Vos; E R Brunt; I Schmitt; T Klockgether; U Wüllner
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

6.  Histone deacetylase inhibitors reduce polyglutamine toxicity.

Authors:  A McCampbell; A A Taye; L Whitty; E Penney; J S Steffan; K H Fischbeck
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

7.  Polyglutamine-expanded spinocerebellar ataxia-7 protein disrupts normal SAGA and SLIK histone acetyltransferase activity.

Authors:  Stacey J McMahon; Marilyn G Pray-Grant; David Schieltz; John R Yates; Patrick A Grant
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-02       Impact factor: 11.205

Review 8.  The role of PML in the nervous system.

Authors:  Paolo Salomoni; Joanne Betts-Henderson
Journal:  Mol Neurobiol       Date:  2010-12-15       Impact factor: 5.590

Review 9.  Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.

Authors:  Gwenn A Garden; Albert R La Spada
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

10.  Nucleocytoplasmic shuttling activity of ataxin-3.

Authors:  Sandra Macedo-Ribeiro; Luísa Cortes; Patrícia Maciel; Ana Luísa Carvalho
Journal:  PLoS One       Date:  2009-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.